Disclosures for "Measuring Synaptic Density and Dopamine Transporter Availability in Parkinson's Disease: A PET Imaging Study with 11C-UCB-J and 18F-FE-PE2I"
-
Mr. Ebrahimian Saadabad has nothing to disclose.
-
Dr. Volpi has nothing to disclose.
-
Mr. Honhar has nothing to disclose.
-
Mika Naganawa has nothing to disclose.
-
Mr. Cayir has nothing to disclose.
-
-
The institution of Jean-Dominique Gallezot has received research support from Bristol Myers Squibb.
-
Dr. Angarita has nothing to disclose.
-
Dr. Holmes has received research support from Michael J Fox foundation .
-
The institution of Prof. E Carson has received research support from Invicro. The institution of Prof. E Carson has received research support from BMS. The institution of Prof. E Carson has received research support from Pfizer. The institution of Prof. E Carson has received research support from Cerevel.
-
-
Dr. Matuskey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Eleisver. The institution of Dr. Matuskey has received research support from Abbvie.